Posted on Apr 30, 2020

SciTech Development

COVID-19 Therapeutic Opportunity: ST-001 nanoFenretinide may offer additional support in the battle against the COVID-19 pandemic. For investment and partnering opportunities contact Lou Scarmoutzos | (617) 283-2182 | lou@scitechdevelopment.com or Earle Holsapple | (313) 263-4887 | eth@scitechdevelopment.com
Contact Us
Message sent. We'll get back to you soon.